The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A Novel Gene, erm (41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
Open accessAbstract
Mycobacterium abscessus infections tend to respond poorly to macrolide-based chemotherapy, even though the organisms appear to be susceptible to clarithromycin. Circumstantial evidence suggested that at least some M. abscessus isolates might be inducibly resistant to macrolides. Thus, the purpose of this study was to investigate the macrolide phenotype of M. abscessus clinical isolates. Inducible resistance to clarithromycin (MIC > 32 μg/ml) was found for 7 of 10 clinical isolates of M. abscessus previously considered susceptible; the remaining 3 isolates were deemed to be susceptible (MIC ≤ 0.5 μg/ml). Inducible resistance was conferred by a novel erm gene, erm (41), which was present in all 10 isolates and in an isolate of Mycobacterium bolletii ( M. abscessus type II). However, the erm (41) alleles were nonfunctional in the three susceptible M. abscessus isolates. No evidence of erm (41) was found in Mycobacterium chelonae , and an isolate of Mycobacterium massiliense appeared to be an erm (41) deletion mutant. Expression of erm (41) in M. abscessus conferred resistance to clarithromycin and erythromycin and the ketolide HMR3004. However, this species was found to be intrinsically resistant, independent of erm (41), to clindamycin, quinupristin (streptogramin B), and telithromycin. The ability to confer resistance to clindamycin and telithromycin, but not quinupristin, was demonstrated by expressing erm (41) in Maycobacterium smegmatis . Exposure of M. abscessus to the macrolide-lincosamide-streptogramin B-ketolide agents increased the levels of erm (41) mRNA 23- to 250-fold within 24 h. The inducible macrolide resistance phenotype of some M. abscessus isolates may explain the lack of efficacy of macrolide-based chemotherapy against this organism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Self-citationMathews, D. H., Sabina, J., Zuker, M., & Turner, D. H. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2700 · Cited by 3,795
Telenti, A., Marchesi, F., Balz, M., Bally, F., Böttger, E. C., & Bodmer, T. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.2.175-178.1993 · Cited by 1,498
New use of BCG for recombinant vaccines
Stover, C. K., de la Cruz, V. F., Fuerst, T. R., Burlein, J. E., Benson, L. A., Bennett, L. T., Bansal, G. P., Young, J. F., Lee, M. H., Hatfull, G. F., et al. (1991) · Nature · doi:10.1038/351456a0 · Cited by 1,490
Brown-Elliott, B. A., & Wallace, R. J. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.716-746.2002 · Cited by 909
Self-citationNomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., & Seppala, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2823 · Cited by 874
Nontuberculous Mycobacteria: I: Multicenter Prevalence Study in Cystic Fibrosis
Olivier, K. N., Weber, D. J., Wallace, R. J., Faiz, A. R., Lee, J.-H., Zhang, Y., Brown-Elliot, B. A., Handler, A., Wilson, R. W., Schechter, M. S., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-678oc · Cited by 631
Self-citationInfections Due to Rapidly Growing Mycobacteria
De Groote, M. A., & Huitt, G. (2006) · Clinical Infectious Diseases · doi:10.1086/504381 · Cited by 429
Ancestral antibiotic resistance in Mycobacterium tuberculosis
Morris, R. P., Nguyen, L., Gatfield, J., Visconti, K., Nguyen, K., Schnappinger, D., Ehrt, S., Liu, Y., Heifets, L., Pieters, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505446102 · Cited by 333
Lindström, K., & Martínez-Romero, M. E. (2005) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.63744-0 · Cited by 314
Brown, B. A., Wallace, R. J., Onyi, G. O., De Rosas, V, & Wallace, R. J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.180 · Cited by 301
Self-citationNontuberculous Mycobacterial Infections: A Clinical Review
Wagner, D., & Young, L. S. (2004) · Infection · doi:10.1007/s15010-004-4001-4 · Cited by 288
Wallace, R. J., Meier, A., Brown, B. A., Zhang, Y., Sander, P., Onyi, G. O., & Böttger, E. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1676 · Cited by 283
Self-citationInsights into erythromycin action from studies of its activity as inducer of resistance
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.797 · Cited by 267
Nontuberculous Mycobacteria, Zambia
Buijtels, P. C. A. M., van der Sande, M. A. B., de Graaff, C. S., Parkinson, S., Verbrugh, H. A., Petit, P. L. C., & van Soolingen, D. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1502.080006 · Cited by 256
Mycobacterium abscessus: an emerging rapid‐growing potential pathogen: Review article
PETRINI, B. (2006) · APMIS · doi:10.1111/j.1600-0463.2006.apm_390.x · Cited by 222
σ Factors and Global Gene Regulation in Mycobacterium tuberculosis
Manganelli, R., Proveddi, R., Rodrigue, S., Beaucher, J., Gaudreau, L., & Smith, I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.4.895-902.2004 · Cited by 214
Brown, B. A., Springer, B., Steingrube, V. A., Wilson, R. W., Pfyffer, G. E., Garcia, M. J., Menendez, M. C., Rodriguez-Salgado, B., Jost, K. C., Chiu, S. H., et al. (1999) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/00207713-49-4-1493 · Cited by 204
Self-citationGryczan, T. J., Grandi, G., Hahn, J., Grandi, R., & Dubnau, D. (1980) · Nucleic Acids Research · doi:10.1093/nar/8.24.6081 · Cited by 200
Geiman, D. E., Raghunand, T. R., Agarwal, N., & Bishai, W. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-06 · Cited by 197
Steingrube, V. A., Gibson, J. L., Brown, B. A., Zhang, Y., Wilson, R. W., Rajagopalan, M., & Wallace, R. J. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.1.149-153.1995 · Cited by 183
Self-citationKetolides lack inducibility properties of MLS(B) resistance phenotype
Bonnefoy, A. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.85 · Cited by 183
The Ketolides: A Critical Review
Zhanel, G. G., Walters, M., Noreddin, A., Vercaigne, L. M., Wierzbowski, A., Embil, J. M., Gin, A. S., Douthwaite, S., & Hoban, D. J. (2002) · Drugs · doi:10.2165/00003495-200262120-00006 · Cited by 183
Molecular Basis of Intrinsic Macrolide Resistance in the Mycobacterium tuberculosis Complex
Buriánková, K., Doucet‐Populaire, F., Dorson, O., Gondran, A., Ghnassia, J. C., Weiser, J., & Pernodet, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.143-150.2004 · Cited by 162
Bashyam, M. D., Kaushal, D., Dasgupta, S. K., et al. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.16.4847-4853.1996 · Cited by 149
Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum
Nash, K. A., Zhang, Y., Brown‐Elliott, B. A., & Wallace, R. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh523 · Cited by 144
Self-citationIntrinsic Macrolide Resistance in Rapidly Growing Mycobacteria
Nash, K. A., Andini, N., Zhang, Y., Brown‐Elliott, B. A., & Wallace, R. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-06 · Cited by 124
Self-citationMeier, A., Heifets, L. B., Wallace, R. J., Zhang, Y., Brown, B. A., Sander, P., & Böttger, E. C. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.354 · Cited by 117
Self-citationActivity of the Ketolide Telithromycin Is Refractory to Erm Monomethylation of Bacterial rRNA
Liu, M., & Douthwaite, S. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1629-1633.2002 · Cited by 108
Barker, L. P., Brooks, D. M., & Small, P. L. C. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00996.x · Cited by 95
Induction of erm (C) Expression by Noninducing Antibiotics
Bailey, M., Chettiath, T., & Mankin, A. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01266-07 · Cited by 93
Identification of Mycobacterial σ Factor Binding Sites by Chromatin Immunoprecipitation Assays
Rodrigue, S., Brodeur, J., Jacques, P., Gervais, A. L., Brzeziński, R., & Gaudreau, L. R. (2006) · Journal of Bacteriology · doi:10.1128/jb.01371-06 · Cited by 86
Intrinsic Macrolide Resistance in Mycobacterium smegmatis Is Conferred by a Novel erm Gene, erm (38)
Nash, K. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3053-3060.2003 · Cited by 80
Self-citationTranslational Attenuation and mRNA Stabilization as Mechanisms of erm (B) Induction by Erythromycin
Min, Y.-H., Kwon, A., Yoon, E.-J., Shim, M.-J., & Choi, E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01376-07 · Cited by 66
Kwak, J., Choi, E. C., & Weisblum, B. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.15.4725-4735.1991 · Cited by 64
Agarwal, N., & Tyagi, A. K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl521 · Cited by 54
Mycobacterium smegmatis Erm(38) Is a Reluctant Dimethyltransferase
Madsen, C. T., Jakobsen, L. A., & Douthwaite, S. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3803-3809.2005 · Cited by 34
Role of mRNA termination in regulation of ermK
Choi, S., Kim, S., Oh, T. G., & Choi, E. C. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.6.2065-2067.1997 · Cited by 20
Cited by
Daley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00535-2020 · Cited by 924
Self-citationDaley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa241 · Cited by 890
Self-citationNon-tuberculous mycobacteria and the rise of Mycobacterium abscessus
Johansen, M. D., Herrmann, J.-L., & Kremer, L. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0331-1 · Cited by 822
Mycobacterium abscessus: a new antibiotic nightmare
Nessar, R., Cambau, E., Reyrat, J. M., Murray, A., & Gicquel, B. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr578 · Cited by 799
Daley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1125 · Cited by 786
Self-citation
Metadata
- Authors
- Nash, K. A., Brown-Elliott, B. A., & Wallace, R. J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-04
- Volume
- 53
- Issue
- 4
- Pages
- 1367-1376
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2162625328
- Cited by
- 638
- References
- 41
- FWCI
- 12.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.